FRAMESHIFT LABS INC
Cambridge, MA · Medtech · Private
Software platform for automated genomic data analysis and re-analysis, prioritizing genetic variants from sequencing data for diagnostic interpretation in undiagnosed disease cases
frameshiftlabs.com →- Grants
- $8.3M
- 12 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Empowering real-time, web-based genomic big data analysis at commercial scale. | $224,920 | |
| Federal grant | Department of Health and Human Services · Phase I · Empowering real-time, web-based genomic big data analysis at commercial scale. | $50,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Visually-driven disease variant analysis empowering real-time clinical research. | $256,443 | |
| Federal grant | Department of Health and Human Services · Phase I · Novel iobio analysis supporting genome scale data quality control. | $249,846 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · IOBIO based, distributed genomic data access, management, visualization, and analysis | $1,962,355 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · IOBIO based, distributed genomic data access, management, visualization, and analysis | $982,303 | |
| Federal grant | Department of Health and Human Services · Phase II · IOBIO based, distributed genomic data access, management, visualization, and analysis | $980,052 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · A web-based platform to support team-based genome diagnostics | $298,855 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · A web-based platform to support team-based genome diagnostics | $298,855 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · A state-of-the-art web platform for collaborative, longitudinal genome diagnostics | $1,000,930 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · A state-of-the-art web platform for collaborative, longitudinal genome diagnostics | $1,000,930 | |
| Federal grant | Department of Health and Human Services · Phase II · A state-of-the-art web platform for collaborative, longitudinal genome diagnostics | $982,368 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1533 | PinkDx, Inc. | — | $17M |
| 1534 | Tactile Analogics LLC | — | — |
| 1535 | EVOKE MEDICAL LLC | — | — |
| 1536 | FRAMESHIFT LABS INC | — | — |
| 1537 | NanoHive Medical LLC | — | $4.0M |
| 1538 | IntuScope, Inc. | — | $1.0M |
| 1539 | Radiatric, Inc. | — | $400K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.